I know people around me probably get tired of hearing me talk about artificial intelligence. What it can do. What it might do. Where it is useful. Where it is overhyped. Where it is dangerous. Where it is just another expensive toy looking for a problem.
Then I run across a story like this.
Researchers at Boston Children’s Hospital, Harvard University, and OpenAI used an AI-assisted workflow to reanalyze 376 previously unsolved pediatric rare-disease cases. These were not simple cases waiting for the first person to look at them. These were specialist dead ends. The children had already gone through genetic testing, expert evaluation, and existing diagnostic pipelines.
The AI model did not diagnose the children. That part matters. Instead, it surfaced leads. Doctors reviewed them. Specialists evaluated them. Additional testing followed, and clinical labs confirmed the results.
In the end, physicians established 18 diagnoses that had previously been missed or unresolved. That is 4.8 percent. That may sound small until you remember what the number means. Eighteen families got an answer.
The Problem With Rare Disease 🧬
Rare disease work is one of the hardest parts of modern medicine. A child has symptoms that do not fit neatly. The family sees specialists. Tests are ordered. Genetic sequencing may be done. Doctors look for known patterns, known variants, known explanations.
Sometimes they find one. More often, they do not.
Boston Children’s notes that even with clinical genetic testing, many children remain without a clear diagnosis. One Boston Children’s rare disease program says clinical genetic testing provides an answer about 30 percent of the time, which leaves many families still searching.
The hard part is that science never stands still. A case that was unsolved five years ago may become solvable later because researchers discover a new gene-disease relationship. A variant once considered uncertain may become meaningful. A case report from another clinic may change how doctors interpret an old result.
But doctors do not have infinite time to reopen every old file every time the literature changes. That is the backlog problem. It is not that nobody cares. It is that the pile is too big, the data is too fragmented, and the research keeps moving.
What The AI Actually Did 🔎
The researchers fed the model de-identified clinical and genomic information from 376 unresolved cases. The model was asked to weigh symptoms, suspect genes, inheritance patterns, public databases, and recent medical literature. It then produced evidence-linked candidate explanations for specialists to review.
That is important. This was not “ChatGPT plays doctor.” Instead, it was more like giving a research assistant a stack of difficult files and asking it to say, “Here are the leads worth checking again, and here is why.”
The medical team then used established clinical frameworks to review the candidates. At least two team members reviewed each candidate. Disagreements were resolved by consensus. The model’s output was never treated as a diagnosis.
That is the version of medical AI I can get behind. Not AI instead of doctors. AI helping doctors get through work that human systems are struggling to revisit at scale.
The 18 Answers ✅
The workflow found 18 confirmed diagnoses out of 376 previously unsolved cases. According to reporting on the study, the diagnoses included:
- 10 among 100 neurodevelopmental cases
- 4 among 61 neuromuscular disease cases
- 2 among 15 early psychosis cases
- 2 among 200 sudden unexpected pediatric death cases
The Part That Should Make Us Mad 😠
Seven of the 18 confirmed diagnoses were not brand-new discoveries. They were rediscoveries.
The answer existed somewhere else: another clinic, another lab, another public database, or another disconnected part of the medical system. It simply never made its way back into the patient’s local record in a useful way.
That means nearly 40 percent of the AI-assisted wins came not from discovering new biology, but from finding things our healthcare information systems had failed to connect. That should bother us.
As a technology problem, this is not mysterious. It is interoperability. It is database plumbing. More specifically, it is record systems that do not talk to each other cleanly. It is also old reports, outside labs, fragmented clinics, and information trapped in places where the next doctor may never see it.
Before we even get to advanced AI medical reasoning, we still have a basic systems problem: the answer can exist and still not reach the family waiting for it. That is not a miracle of artificial intelligence. It is an indictment of the pipes.
Why This Hits Different 💡
This is the kind of AI story I wish more people saw. It is not a chatbot writing bad poetry. It is not a fake image. It is not a company promising that every job will be automated by lunch.
It is a tool that helps experts revisit cases that had already exhausted normal routes.
For a family waiting on a rare-disease diagnosis, an answer can change everything. It can guide treatment. It can end years of guessing. It can connect a child to other patients with the same condition. It can help parents understand whether something is inherited, whether siblings are at risk, or whether a future therapy might apply.
And even when the answer does not fix everything, knowing matters. Anyone who has ever watched a family wait for medical clarity understands that.
The Right Kind of Caution 🧯
The AI did not magically solve medicine. It helped produce leads in 4.8 percent of very difficult cases. That is meaningful, but it is not a miracle button.
It also worked inside a controlled expert workflow. The cases were de-identified. Specialists reviewed the outputs. Testing confirmed the diagnoses. Throughout the process, clinical judgment stayed in the loop. That is the line we should keep repeating. AI should not be handed a child’s symptoms and treated as the final answer.
There is another caution here too. Reasoning models can produce answers that sound very convincing. In rare-disease work, that can be useful, but it can also be dangerous.
The study showed that o3 could connect subtle clues across symptoms, genes, inheritance patterns, and medical literature. That is exactly why it helped. But the same ability can also produce medically plausible ideas that fall apart when actual genetic testing is done.
That is the difference between a lead and a diagnosis. A lead says, “This is worth checking.” By contrast, a diagnosis says, “The evidence confirms it.” AI can help create the first one. Doctors, labs, and clinical judgment still have to establish the second. That distinction is not a technicality. It is the safety system.
But AI may be very good at something humans are bad at: patiently rechecking huge, messy piles of information as new knowledge appears. It does not get tired. It does not forget to search the latest literature. It can compare patterns across databases, gene lists, symptoms, inheritance models, and old reports faster than a human team can do manually. That does not make it wiser than a doctor. It makes it useful to one.
The Bottom Line ✅
People around me may get tired of hearing me talk about AI. Fair enough. Some of the hype deserves every eye roll it gets. But this is why I keep paying attention.
A year-old general research model helped doctors find 18 answers in cases that had already gone cold. Not by replacing medicine. Not by making decisions on its own.
The real lesson is not that AI is ready to replace doctors. It is that medicine has too many cases, too much literature, too many disconnected systems, and too many families waiting for answers that may already be hiding somewhere in the pile.
AI did not solve all of that. Still, it helped point experts back toward leads worth testing.
For 18 families, that may be the beginning of something they had been waiting years to hear. An answer.
And for the rest of us, it is a reminder that sometimes the most powerful use of new technology is not replacing human expertise. It is helping human expertise find what the system lost.
Quick Summary ✅
- The Study: A joint project between Boston Children’s Hospital, Harvard, and OpenAI reanalyzed 376 unsolved pediatric genetic cases using the o3 Deep Research model.
- The Clinical Yield: The automated workflow emerged with critical diagnostics leads that specialists confirmed into 18 definitive answers (a 4.8% incremental gain).
- The Data Plumbing Scandal: Nearly 40% of the active diagnoses (7 out of 18) were classified as “rediscoveries”—answers that already existed in siloed clinical infrastructure but never synced back to local charts.
- Logical Hallucinations: Researchers underscored that while the reasoning model found missing links, it routinely advanced highly convincing, false medical hypotheses that human laboratory verification correctly filtered out.
Related Stories 🔗
- We Can Gate the Danger in AI Without Gating the Benefit
- Why Amazon Says Human-in-the-Loop AI Oversight Is Failing
Upcoming Community Events 📅
- June 17 – July 31, 2026: Together We Thrive community art exhibition on view at the Berea Arts Council gallery.
- June 19–28, 2026: Macbeth final weekend performances at The Spotlight Playhouse.
- July 10–12, 2026: The Berea Craft Festival at Indian Fort Theater.
This article originally appeared on BereaOnline.com — your home for Madison County news, community events, and local updates.
About the Author ✍️
Dr. Chad Hembree serves as the Executive Director of Spotlight Acting School, The Spotlight Playhouse, and Spotlight Performing Arts. His professional history includes 30 years as a certified network engineer and former technology executive, alongside extensive media experience hosting the nationally syndicated radio program Tech Talk. Having operated BereaOnline.com since 1995, his technology journalism focuses on converting complex digital advancements, cloud infrastructures, and emerging tech trends into clear, practical insights for everyday families and local businesses.
Sources 📌
- New England Journal of Medicine (NEJM AI) Research Manifests (June 18, 2026)
- Boston Children’s Hospital Manton Center for Orphan Disease Research Logs (June 2026)
- Becker’s Hospital Review Healthcare IT Systems Infrastructure Studies (June 2026)